| 0 |
PRURITUS |
106 |
| 1 |
DIARRHOEA |
99 |
| 2 |
OFF LABEL USE |
79 |
| 3 |
DRUG INEFFECTIVE |
39 |
| 4 |
LIVER TRANSPLANT |
36 |
| 5 |
PRODUCT DOSE OMISSION ISSUE |
27 |
| 6 |
ABDOMINAL PAIN UPPER |
25 |
| 7 |
HEPATIC ENZYME INCREASED |
25 |
| 8 |
ABDOMINAL PAIN |
22 |
| 9 |
BLOOD BILIRUBIN INCREASED |
22 |
| 10 |
ALANINE AMINOTRANSFERASE INCREASED |
20 |
| 11 |
BILE ACIDS INCREASED |
20 |
| 12 |
VOMITING |
20 |
| 13 |
NAUSEA |
16 |
| 14 |
ASPARTATE AMINOTRANSFERASE INCREASED |
15 |
| 15 |
JAUNDICE |
15 |
| 16 |
TRANSAMINASES INCREASED |
14 |
| 17 |
PRODUCT USE ISSUE |
10 |
| 18 |
WEIGHT DECREASED |
10 |
| 19 |
ABDOMINAL DISCOMFORT |
9 |
| 20 |
DEATH |
8 |
| 21 |
FATIGUE |
8 |
| 22 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
8 |
| 23 |
HYPOVITAMINOSIS |
8 |
| 24 |
INFLUENZA |
8 |
| 25 |
TREATMENT NONCOMPLIANCE |
8 |
| 26 |
CONSTIPATION |
7 |
| 27 |
DEHYDRATION |
7 |
| 28 |
DISEASE PROGRESSION |
7 |
| 29 |
HEADACHE |
7 |
| 30 |
LIVER FUNCTION TEST INCREASED |
7 |
| 31 |
PYREXIA |
7 |
| 32 |
WEIGHT INCREASED |
7 |
| 33 |
BILIRUBIN CONJUGATED INCREASED |
6 |
| 34 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
6 |
| 35 |
HEPATIC CIRRHOSIS |
6 |
| 36 |
ILLNESS |
6 |
| 37 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
6 |
| 38 |
INSOMNIA |
6 |
| 39 |
INTERNATIONAL NORMALISED RATIO INCREASED |
6 |
| 40 |
DECREASED APPETITE |
5 |
| 41 |
DRUG INTOLERANCE |
5 |
| 42 |
HEPATIC FAILURE |
5 |
| 43 |
HEPATIC FUNCTION ABNORMAL |
5 |
| 44 |
HOSPITALISATION |
5 |
| 45 |
INCORRECT DOSE ADMINISTERED |
5 |
| 46 |
LIVER FUNCTION TEST ABNORMAL |
5 |
| 47 |
SEPSIS |
5 |
| 48 |
WEIGHT GAIN POOR |
5 |
| 49 |
ALOPECIA |
4 |
| 50 |
ANAEMIA |
4 |
| 51 |
CHOLESTASIS |
4 |
| 52 |
GASTROINTESTINAL DISORDER |
4 |
| 53 |
GASTROOESOPHAGEAL REFLUX DISEASE |
4 |
| 54 |
HEPATOMEGALY |
4 |
| 55 |
HEPATOTOXICITY |
4 |
| 56 |
PANCREATITIS |
4 |
| 57 |
SCRATCH |
4 |
| 58 |
SPLENOMEGALY |
4 |
| 59 |
THERAPEUTIC RESPONSE UNEXPECTED |
4 |
| 60 |
THERAPY NON-RESPONDER |
4 |
| 61 |
VIRAL INFECTION |
4 |
| 62 |
ABDOMINAL DISTENSION |
3 |
| 63 |
ASTHENIA |
3 |
| 64 |
BLOOD SODIUM DECREASED |
3 |
| 65 |
CHOLELITHIASIS |
3 |
| 66 |
COAGULOPATHY |
3 |
| 67 |
COLITIS |
3 |
| 68 |
CONDITION AGGRAVATED |
3 |
| 69 |
COUGH |
3 |
| 70 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
3 |
| 71 |
DRY SKIN |
3 |
| 72 |
EPISTAXIS |
3 |
| 73 |
FAECES DISCOLOURED |
3 |
| 74 |
FLATULENCE |
3 |
| 75 |
GASTROINTESTINAL HAEMORRHAGE |
3 |
| 76 |
HAEMORRHAGE |
3 |
| 77 |
HEPATIC STEATOSIS |
3 |
| 78 |
HEPATOCELLULAR CARCINOMA |
3 |
| 79 |
INTENTIONAL PRODUCT MISUSE |
3 |
| 80 |
INTENTIONAL PRODUCT USE ISSUE |
3 |
| 81 |
INTENTIONAL UNDERDOSE |
3 |
| 82 |
IRRITABILITY |
3 |
| 83 |
LABORATORY TEST ABNORMAL |
3 |
| 84 |
LIVER DISORDER |
3 |
| 85 |
MALAISE |
3 |
| 86 |
PAIN |
3 |
| 87 |
PNEUMONIA |
3 |
| 88 |
POOR QUALITY SLEEP |
3 |
| 89 |
PRODUCT DOSE OMISSION IN ERROR |
3 |
| 90 |
PRODUCT RESIDUE PRESENT |
3 |
| 91 |
SINUSITIS |
3 |
| 92 |
SLEEP DISORDER |
3 |
| 93 |
UNDERDOSE |
3 |
| 94 |
ACUTE KIDNEY INJURY |
2 |
| 95 |
ACUTE RESPIRATORY FAILURE |
2 |
| 96 |
AGITATION |
2 |
| 97 |
ANXIETY |
2 |
| 98 |
ASCITES |
2 |
| 99 |
BLOOD BILIRUBIN ABNORMAL |
2 |
| 100 |
BLOOD POTASSIUM DECREASED |
2 |
| 101 |
CHOLANGITIS |
2 |
| 102 |
DECREASED ACTIVITY |
2 |
| 103 |
DEFAECATION URGENCY |
2 |
| 104 |
DIPLOPIA |
2 |
| 105 |
DIZZINESS |
2 |
| 106 |
DYSPEPSIA |
2 |
| 107 |
EXPOSURE DURING PREGNANCY |
2 |
| 108 |
FAECES SOFT |
2 |
| 109 |
FEELING ABNORMAL |
2 |
| 110 |
FEELING HOT |
2 |
| 111 |
GAMMA-GLUTAMYLTRANSFERASE DECREASED |
2 |
| 112 |
GASTROENTERITIS |
2 |
| 113 |
GASTROENTERITIS ASTROVIRAL |
2 |
| 114 |
GASTROINTESTINAL PAIN |
2 |
| 115 |
HAEMATOCHEZIA |
2 |
| 116 |
HEAVY MENSTRUAL BLEEDING |
2 |
| 117 |
HEPATIC CANCER |
2 |
| 118 |
HEPATIC ENZYME ABNORMAL |
2 |
| 119 |
HEPATITIS |
2 |
| 120 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
2 |
| 121 |
IRRITABLE BOWEL SYNDROME |
2 |
| 122 |
MALNUTRITION |
2 |
| 123 |
MUCOUS STOOLS |
2 |
| 124 |
MUSCLE SPASMS |
2 |
| 125 |
OCULAR ICTERUS |
2 |
| 126 |
PERIPHERAL SWELLING |
2 |
| 127 |
POLLAKIURIA |
2 |
| 128 |
PORTAL HYPERTENSION |
2 |
| 129 |
PRODUCT SUPPLY ISSUE |
2 |
| 130 |
PRODUCT USE COMPLAINT |
2 |
| 131 |
PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS |
2 |
| 132 |
SKIN ABRASION |
2 |
| 133 |
SOCIAL AVOIDANT BEHAVIOUR |
2 |
| 134 |
TESTICULAR PAIN |
2 |
| 135 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
2 |
| 136 |
THERAPEUTIC RESPONSE DECREASED |
2 |
| 137 |
THERAPEUTIC RESPONSE SHORTENED |
2 |
| 138 |
URTICARIA |
2 |
| 139 |
VITAMIN D DECREASED |
2 |
| 140 |
VOMITING PROJECTILE |
2 |
| 141 |
ABDOMINAL PAIN LOWER |
1 |
| 142 |
ACCIDENTAL UNDERDOSE |
1 |
| 143 |
ACIDOSIS |
1 |
| 144 |
ACUTE SINUSITIS |
1 |
| 145 |
ADENOVIRAL UPPER RESPIRATORY INFECTION |
1 |
| 146 |
ADJUSTMENT DISORDER |
1 |
| 147 |
ADVERSE DRUG REACTION |
1 |
| 148 |
ADVERSE EVENT |
1 |
| 149 |
AGEUSIA |
1 |
| 150 |
ALPHA 1 FOETOPROTEIN INCREASED |
1 |
| 151 |
ANAL INCONTINENCE |
1 |
| 152 |
ANAL INJURY |
1 |
| 153 |
ANAL PRURITUS |
1 |
| 154 |
AORTIC VALVE STENOSIS |
1 |
| 155 |
APPENDICECTOMY |
1 |
| 156 |
APPENDICITIS |
1 |
| 157 |
ARTHRALGIA |
1 |
| 158 |
AST/ALT RATIO ABNORMAL |
1 |
| 159 |
ASTHMA |
1 |
| 160 |
ATTENTION DEFICIT HYPERACTIVITY DISORDER |
1 |
| 161 |
AUTOIMMUNE HEPATITIS |
1 |
| 162 |
BACK PAIN |
1 |
| 163 |
BILE ACID MALABSORPTION |
1 |
| 164 |
BILE ACIDS ABNORMAL |
1 |
| 165 |
BILE DUCT STONE |
1 |
| 166 |
BILIARY COLIC |
1 |
| 167 |
BLINDNESS |
1 |
| 168 |
BLISTER |
1 |
| 169 |
BLOOD BILIRUBIN DECREASED |
1 |
| 170 |
BLOOD BILIRUBIN UNCONJUGATED INCREASED |
1 |
| 171 |
BLOOD FIBRINOGEN INCREASED |
1 |
| 172 |
BLOOD GLUCOSE DECREASED |
1 |
| 173 |
BLOOD GLUCOSE INCREASED |
1 |
| 174 |
BLOOD LACTIC ACID INCREASED |
1 |
| 175 |
BLOOD PRESSURE INCREASED |
1 |
| 176 |
BLOOD SODIUM INCREASED |
1 |
| 177 |
BLOOD TEST ABNORMAL |
1 |
| 178 |
BONE PAIN |
1 |
| 179 |
BOWEL MOVEMENT IRREGULARITY |
1 |
| 180 |
C-REACTIVE PROTEIN INCREASED |
1 |
| 181 |
CARBON DIOXIDE DECREASED |
1 |
| 182 |
CARDIAC DISORDER |
1 |
| 183 |
CEREBROVASCULAR ACCIDENT |
1 |
| 184 |
CHOLESTASIS OF PREGNANCY |
1 |
| 185 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
1 |
| 186 |
COAGULATION TIME ABNORMAL |
1 |
| 187 |
COLD SWEAT |
1 |
| 188 |
COLOUR BLINDNESS |
1 |
| 189 |
CONFUSIONAL STATE |
1 |
| 190 |
CONTUSION |
1 |
| 191 |
COVID-19 |
1 |
| 192 |
CROUP INFECTIOUS |
1 |
| 193 |
CRYING |
1 |
| 194 |
DEAFNESS |
1 |
| 195 |
DEPRESSED MOOD |
1 |
| 196 |
DEPRESSION |
1 |
| 197 |
DEVELOPMENTAL DELAY |
1 |
| 198 |
DIABETIC FOOT INFECTION |
1 |
| 199 |
DISEASE COMPLICATION |
1 |
| 200 |
DIZZINESS POSTURAL |
1 |
| 201 |
DRUG EFFECT LESS THAN EXPECTED |
1 |
| 202 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
1 |
| 203 |
DRUG LEVEL INCREASED |
1 |
| 204 |
DRUG-INDUCED LIVER INJURY |
1 |
| 205 |
DYSENTERY |
1 |
| 206 |
EAR HAEMORRHAGE |
1 |
| 207 |
EAR INFECTION |
1 |
| 208 |
EAR PAIN |
1 |
| 209 |
EATING DISORDER |
1 |
| 210 |
ENTERAL NUTRITION |
1 |
| 211 |
ENTEROVIRUS INFECTION |
1 |
| 212 |
EPILEPSY |
1 |
| 213 |
EXTRA-AXIAL HAEMORRHAGE |
1 |
| 214 |
FAECES PALE |
1 |
| 215 |
FALL |
1 |
| 216 |
FEEDING DISORDER |
1 |
| 217 |
FLUID INTAKE REDUCED |
1 |
| 218 |
FOETAL HYPOKINESIA |
1 |
| 219 |
FREQUENT BOWEL MOVEMENTS |
1 |
| 220 |
FUNGAL INFECTION |
1 |
| 221 |
GAIT DISTURBANCE |
1 |
| 222 |
GASTROENTERITIS VIRAL |
1 |
| 223 |
GASTROINTESTINAL INFECTION |
1 |
| 224 |
GASTROINTESTINAL VIRAL INFECTION |
1 |
| 225 |
GENERAL PHYSICAL HEALTH DETERIORATION |
1 |
| 226 |
GONORRHOEA |
1 |
| 227 |
GROWTH RETARDATION |
1 |
| 228 |
HAEMATEMESIS |
1 |
| 229 |
HAEMATURIA |
1 |
| 230 |
HAEMOGLOBIN DECREASED |
1 |
| 231 |
HEART RATE INCREASED |
1 |
| 232 |
HELICOBACTER INFECTION |
1 |
| 233 |
HEPATIC CANCER RECURRENT |
1 |
| 234 |
HEPATIC ENCEPHALOPATHY |
1 |
| 235 |
HEPATIC FIBROSIS |
1 |
| 236 |
HEPATIC PAIN |
1 |
| 237 |
HEPATOSPLENOMEGALY |
1 |
| 238 |
HERNIA |
1 |
| 239 |
HYPERCHLORAEMIA |
1 |
| 240 |
HYPERCHLORHYDRIA |
1 |
| 241 |
HYPERSENSITIVITY |
1 |
| 242 |
HYPERSPLENISM |
1 |
| 243 |
HYPOAESTHESIA |
1 |
| 244 |
HYPOGLYCAEMIA |
1 |
| 245 |
HYPONATRAEMIC SEIZURE |
1 |
| 246 |
HYPOTHYROIDISM |
1 |
| 247 |
ILEAL ULCER |
1 |
| 248 |
ILL-DEFINED DISORDER |
1 |
| 249 |
IMPAIRED WORK ABILITY |
1 |
| 250 |
INAPPROPRIATE SCHEDULE OF PRODUCT DISCONTINUATION |
1 |
| 251 |
INCONTINENCE |
1 |
| 252 |
INCORRECT DOSAGE ADMINISTERED |
1 |
| 253 |
INCREASED APPETITE |
1 |
| 254 |
INCREASED INSULIN REQUIREMENT |
1 |
| 255 |
INFECTION |
1 |
| 256 |
INSURANCE ISSUE |
1 |
| 257 |
INTENTIONAL DOSE OMISSION |
1 |
| 258 |
INTUSSUSCEPTION |
1 |
| 259 |
INVESTIGATION ABNORMAL |
1 |
| 260 |
IRON DEFICIENCY |
1 |
| 261 |
KNEE OPERATION |
1 |
| 262 |
LEUKODYSTROPHY |
1 |
| 263 |
LIVER INJURY |
1 |
| 264 |
LIVER OPERATION |
1 |
| 265 |
LOSS OF CONSCIOUSNESS |
1 |
| 266 |
LUNG INFILTRATION |
1 |
| 267 |
LYMPHOMA |
1 |
| 268 |
MACULOPATHY |
1 |
| 269 |
MALABSORPTION |
1 |
| 270 |
MEDICATION ERROR |
1 |
| 271 |
MELAENA |
1 |
| 272 |
MENTAL IMPAIRMENT |
1 |
| 273 |
METAPLASIA |
1 |
| 274 |
METASTASES TO LUNG |
1 |
| 275 |
MIDDLE EAR EFFUSION |
1 |
| 276 |
MIDDLE INSOMNIA |
1 |
| 277 |
MITRAL VALVE INCOMPETENCE |
1 |
| 278 |
MODEL FOR END STAGE LIVER DISEASE SCORE INCREASED |
1 |
| 279 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
1 |
| 280 |
MUSCLE TWITCHING |
1 |
| 281 |
MUSCULOSKELETAL PAIN |
1 |
| 282 |
NASAL CONGESTION |
1 |
| 283 |
NEUROLOGICAL SYMPTOM |
1 |
| 284 |
OBSTRUCTION GASTRIC |
1 |
| 285 |
OEDEMA |
1 |
| 286 |
OEDEMA PERIPHERAL |
1 |
| 287 |
ORAL CANDIDIASIS |
1 |
| 288 |
OROPHARYNGEAL PAIN |
1 |
| 289 |
OVERFLOW DIARRHOEA |
1 |
| 290 |
PERICARDIAL EFFUSION |
1 |
| 291 |
PERIORBITAL SWELLING |
1 |
| 292 |
PHARYNGITIS |
1 |
| 293 |
PLEURAL EFFUSION |
1 |
| 294 |
POOR SCHOOL ATTENDANCE |
1 |
| 295 |
PORTAL HYPERTENSIVE GASTROPATHY |
1 |
| 296 |
POST PROCEDURAL DIARRHOEA |
1 |
| 297 |
POST PROCEDURAL INFLAMMATION |
1 |
| 298 |
PRE-EXISTING CONDITION IMPROVED |
1 |
| 299 |
PROCEDURAL COMPLICATION |
1 |
| 300 |
PRODUCT ADMINISTRATION ERROR |
1 |
| 301 |
PRODUCT DISPENSING ERROR |
1 |
| 302 |
PRODUCT DOSAGE FORM ISSUE |
1 |
| 303 |
PRODUCT INEFFECTIVE |
1 |
| 304 |
PRODUCT INFORMATION CONTENT COMPLAINT |
1 |
| 305 |
PRODUCT LABEL CONFUSION |
1 |
| 306 |
PRODUCT PACKAGING ISSUE |
1 |
| 307 |
PRODUCT PREPARATION ISSUE |
1 |
| 308 |
PRODUCT STORAGE ERROR |
1 |
| 309 |
PRODUCT STORAGE ISSUE |
1 |
| 310 |
PRODUCT TASTE ABNORMAL |
1 |
| 311 |
PROTEIN TOTAL DECREASED |
1 |
| 312 |
RECTAL HAEMORRHAGE |
1 |
| 313 |
RENAL CYST |
1 |
| 314 |
RENAL IMPAIRMENT |
1 |
| 315 |
RENAL INJURY |
1 |
| 316 |
RENAL TRANSPLANT |
1 |
| 317 |
RESPIRATORY TRACT INFECTION |
1 |
| 318 |
RESPIRATORY TRACT INFECTION VIRAL |
1 |
| 319 |
RETCHING |
1 |
| 320 |
RHINORRHOEA |
1 |
| 321 |
RHINOVIRUS INFECTION |
1 |
| 322 |
SCAB |
1 |
| 323 |
SCAR |
1 |
| 324 |
SCLERAL DISCOLOURATION |
1 |
| 325 |
SEPTIC SHOCK |
1 |
| 326 |
SKIN BURNING SENSATION |
1 |
| 327 |
SKIN DISORDER |
1 |
| 328 |
SKIN LACERATION |
1 |
| 329 |
SKIN LESION |
1 |
| 330 |
SKIN ODOUR ABNORMAL |
1 |
| 331 |
SLEEP TERROR |
1 |
| 332 |
SOMNOLENCE |
1 |
| 333 |
STAPHYLOCOCCAL BACTERAEMIA |
1 |
| 334 |
STAPHYLOCOCCAL IMPETIGO |
1 |
| 335 |
STOMA CLOSURE |
1 |
| 336 |
STOMA SITE DISCOMFORT |
1 |
| 337 |
STRESS AT WORK |
1 |
| 338 |
SUBDURAL HAEMORRHAGE |
1 |
| 339 |
SUICIDAL IDEATION |
1 |
| 340 |
SUSPECTED DRUG-INDUCED LIVER INJURY |
1 |
| 341 |
TENDONITIS |
1 |
| 342 |
TERMINAL STATE |
1 |
| 343 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
1 |
| 344 |
THERAPEUTIC PRODUCT EFFECTIVE FOR UNAPPROVED INDICATION |
1 |
| 345 |
THERAPEUTIC RESPONSE DELAYED |
1 |
| 346 |
THERAPY CHANGE |
1 |
| 347 |
THROMBOCYTOPENIA |
1 |
| 348 |
TOOTH EXTRACTION |
1 |
| 349 |
TOOTH INFECTION |
1 |
| 350 |
TOTAL BILE ACIDS INCREASED |
1 |
| 351 |
TRANSAMINASES ABNORMAL |
1 |
| 352 |
TRANSFUSION |
1 |
| 353 |
TRANSPLANT REJECTION |
1 |
| 354 |
TREMOR |
1 |
| 355 |
TRICUSPID VALVE INCOMPETENCE |
1 |
| 356 |
TYMPANIC MEMBRANE PERFORATION |
1 |
| 357 |
UNDERWEIGHT |
1 |
| 358 |
UNEVALUABLE EVENT |
1 |
| 359 |
UPPER RESPIRATORY TRACT INFECTION |
1 |
| 360 |
URINARY TRACT INFECTION |
1 |
| 361 |
VARICES OESOPHAGEAL |
1 |
| 362 |
VISION BLURRED |
1 |
| 363 |
VITAMIN K DECREASED |
1 |
| 364 |
VITAMIN K DEFICIENCY |
1 |
| 365 |
WITHDRAWAL HYPERTENSION |
1 |
| 366 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
1 |
| 367 |
YELLOW SKIN |
1 |